Application of metabolomics in the diagnosis of breast cancer: a systematic review
- PMID: 32201524
- PMCID: PMC7066003
- DOI: 10.7150/jca.37604
Application of metabolomics in the diagnosis of breast cancer: a systematic review
Abstract
Breast cancer (BC) remains the most frequent type of cancer in females worldwide. However, the pathogenesis of BC is still under the cloud, along with the huge challenge of early diagnosis, which is widely acknowledged as the key to a successful therapy. Metabolomics, a newborn innovative technique in recent years, has demonstrated great potential in cancer-related researches. The aim of this review is to look back on clinical and cellular metabolomic studies in the diagnosis of BC over the past decade, and provide a systematic summary of metabolic biomarkers and pathways related to BC diagnosis.
Keywords: Breast Cancer; Diagnosis; Metabolomics.
© The author(s).
Conflict of interest statement
Competing Interests: The authors have declared that no competing interest exists.
Figures
References
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2018;68:394–424. - PubMed
-
- Houssami N, Ciatto S, Martinelli F, Bonardi R, Duffy SW. Early detection of second breast cancers improves prognosis in breast cancer survivors. Annals of oncology. 2009;20:1505–10. - PubMed
-
- Duffy MJ. Serum tumor markers in breast cancer: Are they of clinical value? Clinical chemistry. 2006;52:345–51. - PubMed
-
- Armitage EG, Ciborowski M. Applications of metabolomics in cancer studies. Advances in experimental medicine and biology. 2017;965:209–34. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
